The company received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its manufacturing facility located at Central Hope Town, Sellaqul, Industrial Estate, Dehradun.
The scrip opened higher at Rs. 29.20 as against its previous close of Rs. 27.75.It hit a high and a low of Rs. 32.30 and Rs. 28.25 respectively. So far, 21.90 lk share have changed hands on BSE.
The US drug regulator had conducted the inspection in August this year.
In addition, the company is awaiting outcome of the inspection conducted by the USFDA at the compay’s another manufacturing plant located at Taloja.
No comments:
Post a Comment